Galen L. Wampler

2.3k total citations · 1 hit paper
55 papers, 1.8k citations indexed

About

Galen L. Wampler is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Galen L. Wampler has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Galen L. Wampler's work include Lung Cancer Treatments and Mutations (12 papers), Cancer therapeutics and mechanisms (10 papers) and Statistical Methods in Clinical Trials (10 papers). Galen L. Wampler is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer therapeutics and mechanisms (10 papers) and Statistical Methods in Clinical Trials (10 papers). Galen L. Wampler collaborates with scholars based in United States, Greece and Germany. Galen L. Wampler's co-authors include Solomon Zimm, Tapan A. Hazra, Harold F. Young, Bart van’t Riet, Howard L. Elford, C. Djordjević, Walter H. Carter, P. CATSOULACOS, Donald M. Stablein and William Regelson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and JNCI Journal of the National Cancer Institute.

In The Last Decade

Galen L. Wampler

54 papers receiving 1.7k citations

Hit Papers

Intracerebral metastases in solid-tumor patients: Natural... 1981 2026 1996 2011 1981 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
    1981 450 citations Galen L. Wampler et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galen L. Wampler United States 22 760 579 441 314 227 55 1.8k
Vinod F. Patel United States 26 488 0.6× 535 0.9× 535 1.2× 118 0.4× 251 1.1× 81 2.1k
Renzo Canetta United States 30 2.2k 2.8× 502 0.9× 894 2.0× 199 0.6× 185 0.8× 61 3.9k
Steven D. Reich United States 26 787 1.0× 532 0.9× 1.0k 2.4× 126 0.4× 108 0.5× 73 2.3k
Paula M. Fracasso United States 31 1.6k 2.2× 477 0.8× 1.0k 2.3× 136 0.4× 171 0.8× 109 3.0k
H. M. Pinedo Netherlands 34 1.9k 2.4× 361 0.6× 1.4k 3.2× 177 0.6× 157 0.7× 101 3.4k
Dale Miles United States 23 635 0.8× 575 1.0× 663 1.5× 223 0.7× 57 0.3× 70 1.6k
Tom Anderson United States 32 1.6k 2.1× 820 1.4× 730 1.7× 377 1.2× 238 1.0× 88 3.7k
Matthijs M. Tibben Netherlands 21 832 1.1× 175 0.3× 428 1.0× 95 0.3× 67 0.3× 58 1.5k
Benjamin Winograd Netherlands 21 1.3k 1.7× 168 0.3× 928 2.1× 146 0.5× 69 0.3× 56 2.3k

Countries citing papers authored by Galen L. Wampler

Since Specialization
Citations

This map shows the geographic impact of Galen L. Wampler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen L. Wampler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen L. Wampler more than expected).

Fields of papers citing papers by Galen L. Wampler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galen L. Wampler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen L. Wampler. The network helps show where Galen L. Wampler may publish in the future.

Co-authorship network of co-authors of Galen L. Wampler

This figure shows the co-authorship network connecting the top 25 collaborators of Galen L. Wampler. A scholar is included among the top collaborators of Galen L. Wampler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galen L. Wampler. Galen L. Wampler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahlgren, James D., Neil M. Ellison, Jacob J. Lokich, et al.. (1993). Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.. Journal of Clinical Oncology. 11(10). 1957–1968. 90 indexed citations
3.
Case, Delvyn C., Robert W. Carey, David H. Henry, et al.. (1993). Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy. JNCI Journal of the National Cancer Institute. 85(10). 801–806. 154 indexed citations
4.
Rosenthal, C. Julian, Galen L. Wampler, Harmar D. Brereton, et al.. (1992). A Study of Oral Etoposide, Infusional Cisplatin, and Infusional 5-Fluorouracil for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 15(1). 12–17. 4 indexed citations
5.
Wampler, Galen L., et al.. (1992). Relationships between various uses of antineoplastic drug-interaction terms. Cancer Chemotherapy and Pharmacology. 31(2). 111–117. 9 indexed citations
6.
Wampler, Galen L., James D. Ahlgren, & Richard S. Schulof. (1992). A Pilot Study of Intensive Weekly Chemotherapy for Extensive Disease Small-Cell Lung Carcinoma. Cancer Investigation. 10(2). 97–102. 4 indexed citations
7.
Heim, W., Galen L. Wampler, J Lokich, et al.. (1991). A study of infusional cisplatin and infusional fluorouracil for locally advanced or metastatic non-small-cell lung cancer: a Mid-Atlantic Oncology Program study.. Journal of Clinical Oncology. 9(12). 2162–2166. 15 indexed citations
8.
9.
Srimuninnimit, Vichien & Galen L. Wampler. (1991). Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil. Cancer Chemotherapy and Pharmacology. 28(3). 217–219. 9 indexed citations
10.
Wampler, Galen L., James D. Ahlgren, Jacob J. Lokich, John J. Gullo, & James A. Phillips. (1991). Dichloromethotrexate, Infusional Cisplatin, and Infusional 5-Fluorouracil for Locally Advanced or Metastatic Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 14(5). 442–445. 1 indexed citations
11.
12.
Prentice, Ross L., et al.. (1984). Regression Analysis of Survival Data in Cancer Chemotherapy.. Biometrics. 40(1). 282–282. 44 indexed citations
13.
Wampler, Galen L., et al.. (1983). Brief communication: Hexamethylmelamine in adenocarcinoma of the pancreas and liver. Medical and Pediatric Oncology. 11(4). 297–298. 1 indexed citations
14.
15.
Wampler, Galen L., et al.. (1982). A pilot study with ethyl bis (2,2-dimethyl-1-aziridinyl) phosphinate (AB-163) and radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 8(7). 1219–1223. 3 indexed citations
16.
Segreti, Anthony C., Walter H. Carter, & Galen L. Wampler. (1981). A monte carlo evaluation of the robustness of several sequential optimization techniques when the response is time to an event. Journal of Statistical Computation and Simulation. 12(3-4). 209–216. 1 indexed citations
17.
Hahn, Robert G., et al.. (1979). Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(3). 513–5. 24 indexed citations
18.
Spremulli, Ellen N., Galen L. Wampler, William Regelson, Dennis Borochovitz, & Thomas G. Hardy. (1977). Chemotherapy of malignant mesothelioma. Cancer. 40(5). 2038–2045. 17 indexed citations
19.
Hsiao, Yi, Thomas J. Bardos, Galen L. Wampler, & William Regelson. (1975). Synthesis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents. Journal of Medicinal Chemistry. 18(2). 195–198. 5 indexed citations
20.
Munson, Albert E., et al.. (1972). Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response.. PubMed. 32(7). 1397–403. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinod F. Patel Breakdown of academic impact, for papers by Renzo Canetta Breakdown of academic impact, for papers by Steven D. Reich Breakdown of academic impact, for papers by Paula M. Fracasso Breakdown of academic impact, for papers by H. M. Pinedo Breakdown of academic impact, for papers by Dale Miles Breakdown of academic impact, for papers by Tom Anderson Breakdown of academic impact, for papers by Matthijs M. Tibben Breakdown of academic impact, for papers by Benjamin Winograd
Rankless by CCL
2026